WebJemincare (济民可信) is a company that focuses on research and development, production, and marketing of medicine, biological agents, and health care products. It specializes in the development and manufacture of kidney disease, anti-tumor, cardiovascular, anti-infection, first aid, and pediatric medicine. Type Private Web12 mag 2024 · Orion Corp. has secured exclusive global rights, outside China, to a non-opioid pain drug candidate from Jiangxi Jemincare Group Co. Ltd. The deal, for oral sodium channel inhibitor JMKX-000623, brought Jemincare €15 million (US$15.6 million) up front. In addition, Orion could pay the Chinese company development, …
Breakthrough Discoveries on Novel Features of Omicron
Web1 ago 2024 · The table to the right includes counts of all research outputs for Jiangxi Jemincare Group Co., Ltd. published between 1 August 2024 - 31 July 2024 which are … Web6 mag 2024 · Founded in 1999, Jemincare group has over 10,000 employees dedicated to the development, manufacturing and commercialisation of therapeutics in its strategic … curved pet scissors
Jemincare Announces Exclusive License Agreement with …
WebJemincare (济民可信) is a company that focuses on research and development, production, and marketing of medicine, biological agents, and health care products. It specializes in … Web16 feb 2024 · Shanghai Jemincare Pharmaceuticals Co. Ltd, Jemincare Group Research Institute, 1118 Halei Road, Shanghai, 201203 P. R. China Search for more papers by this author Wenbiao Wu , Web28 giu 2024 · Abstract: A compound represented by formula (I), an optical isomer thereof and a pharmaceutically acceptable salt thereof, as well as an application of said compound as an FXIa inhibitor. Type: Grant. Filed: June 28, 2024. Date of Patent: December 6, 2024. Assignees: SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD., JIANGXI … chase firestone card